Compare · BSX vs WOK
BSX vs WOK
Side-by-side comparison of Boston Scientific Corporation (BSX) and WORK Medical Technology Group LTD (WOK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BSX and WOK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- BSX is the larger of the two at $63.97B, about 10685.4x WOK ($6.0M).
- BSX has hit the wire 5 times in the past 4 weeks while WOK has been quiet.
- BSX has more recent analyst coverage (25 ratings vs 0 for WOK).
- Company
- Boston Scientific Corporation
- WORK Medical Technology Group LTD
- Price
- -
- -
- Market cap
- $63.97B
- $6.0M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2024
- News (4w)
- 5
- 0
- Recent ratings
- 25
- 0
Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Latest BSX
- Barclays initiated coverage on Boston Scientific with a new price target
- SEC Form 8-K filed by Boston Scientific Corporation
- Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer
- Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
- Boston Scientific Corporation filed SEC Form 8-K: Leadership Update
- Boston Scientific downgraded by Citigroup with a new price target
- SEC Form 8-K filed by Boston Scientific Corporation
- SEC Form 4 filed by Boston Scientific Corporation
- Director Morano Susan E bought $100,408 worth of shares (2,040 units at $49.22), increasing direct ownership by 17% to 13,784 units (SEC Form 4)
- Boston Scientific Corporation filed SEC Form 8-K: Other Events
Latest WOK
- SEC Form 6-K filed by WORK Medical Technology Group LTD
- SEC Form 6-K filed by WORK Medical Technology Group LTD
- Large owner Hrt Financial Lp bought $40,501 worth of shares (880,456 units at $0.05) and sold $528,894 worth of shares (136,665 units at $3.87), decreasing direct ownership by 68% to 123,944 units (SEC Form 4)
- Large owner Hrt Financial Lp bought $25,548 worth of shares (268,927 units at $0.10) and sold $168,465 worth of shares (2,904,567 units at $0.06), decreasing direct ownership by 87% to 391,456 units (SEC Form 4)
- Large owner Hrt Financial Lp bought $3,849 worth of shares (48,108 units at $0.08), increasing direct ownership by 2% to 3,027,096 units (SEC Form 4)
- WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026
- Large owner Hrt Financial Lp bought $363,500 worth of shares (3,794,711 units at $0.10) (SEC Form 4)
- New insider Hrt Financial Lp claimed ownership of 949,661 shares (SEC Form 3)
- Large owner Hrt Financial Lp sold $363,617 worth of shares (3,463,022 units at $0.10), closing all direct ownership in the company (SEC Form 4)
- Large owner Hrt Financial Lp bought $239,679 worth of shares (2,261,118 units at $0.11), increasing direct ownership by 586% to 2,647,299 units (SEC Form 4)